Group 1 - The core point of the news is that Aopumai's stock price has decreased by 5.02%, currently trading at 55.87 CNY per share, with a total market capitalization of 6.359 billion CNY [1] - Aopumai Biotechnology Co., Ltd. was established on November 27, 2013, and went public on September 2, 2022. The company specializes in cell culture products and services, with product revenue accounting for 87.34% and service revenue for 12.53% [1] Group 2 - From the perspective of major fund holdings, Guotai Fund has a significant position in Aopumai, with its Guotai National Policy Driven Flexible Allocation Mixed A Fund holding 3,140 shares, representing 0.65% of the fund's net value [2] - The Guotai National Policy Driven Flexible Allocation Mixed A Fund has a total scale of 21.707 million CNY and has achieved a year-to-date return of 3.97% [2] - The fund manager, Deng Shifeng, has a tenure of 17 years and has achieved the best fund return of 167.36% during his management period [2]